Literature DB >> 191657

Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains.

W Drohan, R Kettmann, D Colcher, J Schlom.   

Abstract

Radioactive 60-70S RNA from the mouse mammary tumor virus (MMTV) produced by the C3H mouse mammary tumor cell line (Mm5mt) hybridized to a greater extent, and at a lower Cot1/2 value, to the DNA of C3H mammary tumor cells than to the DNA of C3H liver cells. The 125I-labeled MMTV (C3H) 60-40S RNA was annealed to a vast excess of DNA from C3H livers, and single-stranded RNA was eluted from hydroxylapatite and recovered. This "recycled RNA" did not hybridize to the DNA of the apparently normal organs tested from normal or from mammary tumor-bearing C3H mice, but hybridized extensively to both the DNA from the C3H mammary tumor cell line and the DNA from spontaneous C3H mammary tumors. This hybridization could be competed out by the addition of unlabeled MMTV 60-70S RNA but was unaffected by the addition of unlabeled 60-70S RNA of C3H type C virus. Similar experiments were conducted with the RIII mouse strain. We therefore report on the isolation of the sequences of the RNA genomes of the MMTVs from C3H and RIII mice that are transmitted by some mechanism other than via the germ line. These studies further define the differences, via molecular hybridization, between the MMTV-S and the MMTV-L in both C3H and RIII mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191657      PMCID: PMC515638     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  ON THE SIGNIFICANCE OF VIRUS-LIKE PARTICLES IN MAMMARY TISSUES OF C3HF MICE.

Authors:  D R PITELKA; H A BERN; S NANDI; K B DEOME
Journal:  J Natl Cancer Inst       Date:  1964-11       Impact factor: 13.506

2.  Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production.

Authors:  U R Rapp; R C Nowinski; C A Reznikoff; C Heidelberger
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

3.  C3H-Avy--a high hepatoma and high mammary tumor strain of mice.

Authors:  W E Heston; G Vlahakis
Journal:  J Natl Cancer Inst       Date:  1968-06       Impact factor: 13.506

4.  Characterization of mouse mammary tumor viruses from primary tumor cell cultures. II. Biochemical and biophysical studies.

Authors:  P C Kimball; R Michalides; D Colcher; J Schlom
Journal:  J Natl Cancer Inst       Date:  1976-01       Impact factor: 13.506

5.  Relationship in nucleic acid sequences between mouse mammary tumor virus variants.

Authors:  R Michalides; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

6.  Acquisition of viral DNA sequences in target organs of chickens infected with avian myeloblastosis virus.

Authors:  M Shoyab; M A Baluda
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

7.  Characterization of mouse mammary tumor viruses from primary tumor cell cultures.I. Immunologic and structural studies.

Authors:  P C Kimball; M Boehm-Truitt; G Schochetman; J Schlom
Journal:  J Natl Cancer Inst       Date:  1976-01       Impact factor: 13.506

8.  Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences.

Authors:  E M Scolnick; R J Goldberg; D Williams
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

9.  A biochemical approach to the study of the transmission of mouse mammary tumor viruses in mouse strains RIII and C3H.

Authors:  R Michalides; G Vlahakis; J Schlom
Journal:  Int J Cancer       Date:  1976-07-15       Impact factor: 7.396

10.  In vitro system for production of mouse mammary tumor virus.

Authors:  D L Fine; L O Arthur; J K PLOWMAN; E A Hillman; F Klein
Journal:  Appl Microbiol       Date:  1974-12
View more
  18 in total

1.  Identification of the Mtv-2 gene responsible for the early appearance of mammary tumors in the GR mouse by nucleic acid hybridization.

Authors:  R Michalides; L van Deemter; R R Nuss; R van Nie
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 2.  Subline divergence within L.C. Strong's C3H and CBA inbred mouse strains. A review.

Authors:  A C Whitmore; S P Whitmore
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  Involvement of mouse mammary tumor virus in spontaneous and hormone-induced mammary tumors in low-mammary-tumor mouse strains.

Authors:  R Michalides; L van Deemter; R Nusse; G Röpcke; L Boot
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

4.  Murine mammary tumor virus expression during mammary tumorigenesis in BALB/c mice.

Authors:  R J Pauley; D Medina; S H Socher
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Isolation of host-range variants of mouse mammary tumor viruses that efficiently infect cells in vitro.

Authors:  D K Howard; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Strain-specific markers for the major structural proteins of highly oncogenic murine mammary tumor viruses by tryptic peptide analyses.

Authors:  J W Gautsch; R Lerner; D Howard; Y A Teramoto; J Schlom
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

7.  Distribution of Mason-Pfizer virus-specific sequences in the DNA of primates.

Authors:  W Drohan; D Colcher; G Schochetman; J Schlom
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

8.  Isolation and characterization of germ line DNA from mouse sperm.

Authors:  R Shiurba; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation.

Authors:  D K Howard; J Schlom; P B Fisher
Journal:  In Vitro       Date:  1983-01

10.  Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment.

Authors:  M J Yagi; N W King; J G Bekesi
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.